Cargando…
Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
Immunomagnetic reduction (IMR), which involves the use of antibody-functionalized magnetic nanoparticles to specifically label target biomarkers, was utilized to develop an assay for total tau protein in human plasma. The analytic properties of the IMR assay on tau protein were investigated. The lim...
Autores principales: | Yang, Shieh-Yueh, Chiu, Ming-Jang, Chen, Ta-Fu, Lin, Chin-Hsien, Jeng, Jiann-Shing, Tang, Sung-Chun, Lee, Yen-Fu, Yang, Che-Chuan, Liu, Bing-Hsien, Chen, Hsin-Hsien, Wu, Chau-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571227/ https://www.ncbi.nlm.nih.gov/pubmed/28839167 http://dx.doi.org/10.1038/s41598-017-09009-3 |
Ejemplares similares
-
Integrated (18)F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders
por: Li, Cheng-Hsuan, et al.
Publicado: (2021) -
Synergistic Association between Plasma Aβ(1–42) and p-tau in Alzheimer’s Disease
but Not in Parkinson’s Disease or Frontotemporal Dementia
por: Chiu, Ming-Jang, et al.
Publicado: (2021) -
Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
por: Lin, Chin-Hsien, et al.
Publicado: (2020) -
Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
por: Yang, Shieh-Yueh, et al.
Publicado: (2016) -
Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)